| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 7,678,600 | 7,394,200 | 6,939,900 | 7,836,200 | 7,024,500 |
| Sales Growth | +3.85% | +6.55% | -11.44% | +11.56% | -12.00% |
| Net Income | 903,700 | 1,024,000 | 231,400 | 401,600 | -138,900 |
| Net Income Growth | -11.75% | +342.52% | -42.38% | +389.13% | -112.27% |
Zimmer Biomet Holdings (ZBH)
110.50 x 1 115.39 x 1
Post-market by (Cboe BZX)
110.73 -1.05 (-0.94%) 03/21/25 [NYSE]
110.50 x 1 115.39 x 1
Post-market 110.70 -0.03 (-0.03%) 18:47 ET
for Fri, Mar 21st, 2025
Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
Fiscal Year End Date: 12/31